Scilex Holding Co. Announces 2024 Annual Meeting of Stockholders

Ticker: SCLXW · Form: DEF 14A · Filed: Mar 12, 2024 · CIK: 1820190

Scilex Holding Co DEF 14A Filing Summary
FieldDetail
CompanyScilex Holding Co (SCLXW)
Form TypeDEF 14A
Filed DateMar 12, 2024
Risk Levellow
Pages16
Reading Time20 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: Scilex Holding, Annual Meeting, Proxy Statement, Virtual Meeting, Director Election

TL;DR

<b>Scilex Holding Company will host its 2024 Annual Meeting of Stockholders virtually on April 5, 2024, to elect directors and ratify auditors.</b>

AI Summary

Scilex Holding Co (SCLXW) filed a Proxy Statement (DEF 14A) with the SEC on March 12, 2024. Scilex Holding Company will hold its 2024 Annual Meeting of Stockholders virtually on April 5, 2024, at 9:00 a.m. Pacific Time. The meeting will be conducted via live audio webcast at www.virtualshareholdermeeting.com/SCLX2024. Stockholders will vote on the election of two Class II directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024. The virtual format is intended to provide expanded access, lower costs, and align with sustainability goals. Stockholders of record attending the virtual meeting will have similar participation rights as at an in-person meeting.

Why It Matters

For investors and stakeholders tracking Scilex Holding Co, this filing contains several important signals. The shift to a virtual-only meeting aims to reduce costs and improve accessibility for stockholders, potentially increasing participation. Holding the meeting virtually aligns with the company's sustainability goals, reflecting a modern approach to corporate governance.

Risk Assessment

Risk Level: low — Scilex Holding Co shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain significant new financial or operational information, thus posing minimal risk.

Analyst Insight

Stockholders should review the proxy materials to understand the proposals, particularly the director elections and auditor ratification, and vote accordingly.

Key Numbers

  • 2 — Class II directors (Number of directors to be elected)
  • 2027 — Annual meeting (Term for elected directors)
  • 9:00 a.m. Pacific Time — Meeting time (Time of the Annual Meeting)

Key Players & Entities

  • Scilex Holding Co (company) — Registrant name
  • Ernst & Young LLP (company) — Independent registered public accounting firm
  • April 5, 2024 (date) — Date of Annual Meeting
  • 2024 (date) — Fiscal year for auditor ratification

FAQ

When did Scilex Holding Co file this DEF 14A?

Scilex Holding Co filed this Proxy Statement (DEF 14A) with the SEC on March 12, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Scilex Holding Co (SCLXW).

Where can I read the original DEF 14A filing from Scilex Holding Co?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Scilex Holding Co.

What are the key takeaways from Scilex Holding Co's DEF 14A?

Scilex Holding Co filed this DEF 14A on March 12, 2024. Key takeaways: Scilex Holding Company will hold its 2024 Annual Meeting of Stockholders virtually on April 5, 2024, at 9:00 a.m. Pacific Time.. The meeting will be conducted via live audio webcast at www.virtualshareholdermeeting.com/SCLX2024.. Stockholders will vote on the election of two Class II directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024..

Is Scilex Holding Co a risky investment based on this filing?

Based on this DEF 14A, Scilex Holding Co presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting and does not contain significant new financial or operational information, thus posing minimal risk.

What should investors do after reading Scilex Holding Co's DEF 14A?

Stockholders should review the proxy materials to understand the proposals, particularly the director elections and auditor ratification, and vote accordingly. The overall sentiment from this filing is neutral.

How does Scilex Holding Co compare to its industry peers?

Scilex Holding Company operates in the biotechnology and pharmaceutical sector, focusing on developing and commercializing novel treatments.

Are there regulatory concerns for Scilex Holding Co?

The filing is a Schedule 14A (DEF 14A), which is a definitive proxy statement required by the SEC for public companies soliciting shareholder votes.

Risk Factors

  • Virtual Meeting Format [low — operational]: The company is holding its annual meeting virtually, which may present challenges in direct stockholder engagement compared to an in-person meeting.

Industry Context

Scilex Holding Company operates in the biotechnology and pharmaceutical sector, focusing on developing and commercializing novel treatments.

Regulatory Implications

The filing is a Schedule 14A (DEF 14A), which is a definitive proxy statement required by the SEC for public companies soliciting shareholder votes.

What Investors Should Do

  1. Review the proxy statement for details on director nominees and the proposed independent auditor.
  2. Vote on the election of Class II directors and the ratification of Ernst & Young LLP.
  3. Participate in the virtual Annual Meeting on April 5, 2024, to ask questions and cast votes.

Key Dates

  • 2024-04-05: Annual Meeting of Stockholders — Key date for voting on director elections and auditor ratification.

Year-Over-Year Comparison

This is a definitive proxy statement (DEF 14A) for the 2024 Annual Meeting, indicating a routine corporate governance filing.

Filing Stats: 4,909 words · 20 min read · ~16 pages · Grade level 12.4 · Accepted 2024-03-12 16:47:57

Key Financial Figures

  • $0.0001 — Holders of our common stock, par value $0.0001 per share (Common Stock), and holders o

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 31 EQUITY COMPENSATION PLAN INFORMATION 37

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 39 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 41 HOUSEHOLDING OF PROXY MATERIALS 49 OTHER MATTERS 49 i Table of Contents SCILEX HOLDING COMPANY PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS PROCEDURAL MATTERS This proxy (the Annual Meeting) of Scilex Holding Company, a Delaware corporation (the Company, Scilex, we, us or our), and any adjournments or postponements thereof. The Annual Meeting will be held virtually on Friday, April 5, 2024, at 9:00 a.m. Pacific Time via live audio webcast. This Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are first being mailed on or about March 12, 2024 to all stockholders of record entitled to vote at the Annual Meeting. The information provided in the question and answer format below is for your convenience only and is merely a summary of the information contained in this Proxy Statement. You should read this entire Proxy Statement carefully. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this Proxy Statement, and references to our website address in this Proxy Statement are inactive textual references only. What matters am I voting on? You will be voting on: the election of two Class II directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified; the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024; and any other business as may properly come before the Annual Meeting. How does the board of directors recommend

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.